
Sign up to save your podcasts
Or
Hypercalcemia of malignancy (HCM) affects about 30% of all patients with cancer. Patients with breast cancer that has metastasized to bone and patients with squamous cell lung cancer together account for more than half of all HCM cases. ONS member Marcelle Kaplan, RN, MS, CNS, CBCN®–Emeritus, AOCN®–Emeritus, breast oncology clinical specialist and member of the Long Island/Queens ONS Chapter, and Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, discuss hypercalcemia of malignancy and its current treatment strategies. This episode is part of a series about oncologic emergencies; the other episodes are linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center’s Commission on Accreditation.
Episode Notes
Check out these resources from today’s episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email [email protected].
4.6
185185 ratings
Hypercalcemia of malignancy (HCM) affects about 30% of all patients with cancer. Patients with breast cancer that has metastasized to bone and patients with squamous cell lung cancer together account for more than half of all HCM cases. ONS member Marcelle Kaplan, RN, MS, CNS, CBCN®–Emeritus, AOCN®–Emeritus, breast oncology clinical specialist and member of the Long Island/Queens ONS Chapter, and Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, discuss hypercalcemia of malignancy and its current treatment strategies. This episode is part of a series about oncologic emergencies; the other episodes are linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center’s Commission on Accreditation.
Episode Notes
Check out these resources from today’s episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email [email protected].
171,556 Listeners
3,321 Listeners
366,757 Listeners
69,203 Listeners
1,308 Listeners
47,207 Listeners
57,370 Listeners
5,286 Listeners
548 Listeners
41,391 Listeners
170 Listeners
4,622 Listeners
152 Listeners
5,239 Listeners
6,568 Listeners